We are live on ! Find out more
ISEE

IVERIC bio, Inc. Common Stock

Delisted

ISEE was delisted on the 10th of July, 2023.

98 hedge funds and large institutions have $1.18B invested in IVERIC bio, Inc. Common Stock in 2014 Q2 according to their latest regulatory filings, with 39 funds opening new positions, 38 increasing their positions, 15 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more first-time investments, than exits

New positions opened: 39 | Existing positions closed: 13

153% more repeat investments, than reductions

Existing positions increased: 38 | Existing positions reduced: 15

54% more capital invested

Capital invested by funds: $768M → $1.18B (+$412M)

50% more funds holding in top 10

Funds holding in top 10: 46 (+2)

34% more funds holding

Funds holding: 7398 (+25)

58% less call options, than puts

Call options by funds: $2.34M | Put options by funds: $5.54M

Holders
98
Holders Change
+25
Holders Change %
+34.25%
% of All Funds
2.82%
Holding in Top 10
6
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+50%
% of All Funds
0.17%
New
39
Increased
38
Reduced
15
Closed
13
Calls
$2.34M
Puts
$5.54M
Net Calls
-$3.2M
Net Calls Change
+$3.12M
Name Holding Trade Value Shares
Change
Change in
Stake
PCM
101
Pentwater Capital Management
Florida
-$1.43M -40,000 Closed
RG
102
Redmile Group
California
-$692K -19,374 Closed
Wellington Management Group
103
Wellington Management Group
Massachusetts
-$679K -19,000 Closed
SM
104
Sabby Management
Florida
-$570K -15,944 Closed
Stifel Financial
105
Stifel Financial
Missouri
-$390K -10,922 Closed
Marshall Wace
106
Marshall Wace
United Kingdom
-$300K -8,400 Closed
BJ
107
BlackRock Japan
Japan
-$247K -6,912 Closed
SG Americas Securities
108
SG Americas Securities
New York
-$209K -5,852 Closed
SO
109
STRS Ohio
Ohio
-$129K -3,600 Closed
PAM
110
Panagora Asset Management
Massachusetts
-$29K -813 Closed
TDC
111
Thompson Davis & Co
Virginia
-$18K -500 Closed

ISEE Hedge Fund Activity: Q2 2014 in Review

98 of the 3,479 institutional investors tracked by Wall St. Rank reported a position in IVERIC bio, Inc. Common Stock (ISEE) for Q2 2014, worth a combined $1.18B — up 54% from $768M a quarter earlier.

Buyers outnumbered sellers: 39 funds opened new ISEE positions and 13 closed out — a net gain of 26 holders — while 38 added to existing stakes and 15 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $68.3M. The largest seller was Clarus Ventures, cutting an estimated $55M.

  • 98 institutional investors held IVERIC bio, Inc. Common Stock (ISEE) as of Q2 2014, up from 73 in Q1 2014.
  • Funds reported $1.18B of IVERIC bio, Inc. Common Stock stock for Q2 2014, up 54% quarter-over-quarter.
  • 39 funds opened new IVERIC bio, Inc. Common Stock positions in Q2 2014 and 13 closed out, a net change of +26 holders.
  • The largest IVERIC bio, Inc. Common Stock buyer in Q2 2014 was Fidelity Investments, an estimated $68.3M added.
  • The largest IVERIC bio, Inc. Common Stock seller in Q2 2014 was Clarus Ventures, an estimated $55M sold.

Based on aggregated 13F filings for Q2 2014.